When a patient says, "I don't want intubation", many doctors stop there. Don't stop there. Ask why they say that. Ask what makes their life meaningful. You need to explore the reason behind it.

Most viewed in the last 7 days from JAMA Internal Medicine: Clinical Insights by Tim Anderson and @ZacharyGJacobs proposes a new framework for managing asymptomatic blood pressure elevation in the hospital setting. ja.ma/3yqQ64L

Day made thanks to ASCO TECAG ASCO for providing a platform for young trainees at #ASCO24 as we presented our work from Yale Internal Medicine Yale Cancer Center Paul Stockhammer Michael Grant! Fernando Diaz, MD Jacob J. Adashek, DO

Former YouTube CEO Susan Wojcicki passed away yesterday at age 56 from #lungcancer. If you have lungs, you can get lung cancer. #LCSM cnn.com/2024/08/10/bus…

Five-year survival in pts with #SCLC treated with first-line carboplatin, etoposide, and atezolizumab (IMpower 133 to IMbrella A extension) Lung Cancer Journal. 3y OS rate 16%, 4y OS 13%, 5y OS 12%. Confirms long-term survival possible for subset of pts. lungcancerjournal.info/article/S0169-…

Very cool cross-trial comparison of 1st line PD1 + CTLA-4 versus PD1 + LAG-3 strategy (in advanced melanoma). Similar efficacy but slightly better safety with LAG-3 combo. Journal of Clinical Oncology Improves our understanding of the 3rd CPI. OncoAlert ascopubs.org/doi/full/10.12…

JUST IN: U.S. FDA approves neoadjuvant/adjuvant Durvalumab in non small cell lung cancer, via CancerNetwork® cancernetwork.com/view/neoadjuva…

✍️Mark your calendar for our next upcoming space‼️ Fellowship Application; The Program Director Perspective, with Dr. Rami Manochakian, Heme/onc Fellowship PD at Mayo Clinic FL❗️ 📅 Wednesday, 21st August 2024 ⏰ 7 pm EST Moderator: Noha N. Soror, MD, MSc. 𓂀 🌟Speaker: Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation

What happened when MIT stopped paying Elsevier? Not much except they are saving a lot of money. "MIT is interested in collaborating with other libraries to reinvest these funds in community-controlled open publishing initiatives..." sparcopen.org/our-work/big-d…

Since price gouging and profit margins are trending ...

Below is a list of "Never Words" to avoid around patients. 🧐 doi.org/10.1016/j.mayo…

Perhaps this should have been titled “Ode to a Code”: 🤔 You're Just Too Good to Be True: Billing for Longitudinal Care With G2211 | JCO Oncology Practice ascopubs.org/doi/10.1200/OP…

Dendritic Cell–Based Immunotherapy in Patients With Resected Pancreatic Cancer | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Legitimately practice changing: the #TIGHTK multicenter open label RCT found that in post-op cardiac surgery patients, repleting potassium to 3.6 mEq/L was non-inferior 4.5 mEq/L but saved substantial RN ⏱️ time & 💰 money ($111 per pt). jamanetwork.com/journals/jama/…

Should we get rethink the full (complete) blood count? Burack et al. argue for a change - to get rid of many values & using two streamlined versions of - maintaining the comprehensive count only when clinically indicated. Link to ASH Clinical News article below.

Glad to share our new publication- “Grade 4 adverse bleeding diathesis related to Ibrutinib”. Thanks to the program leadership for the constant support. Geetha Krishnamoorthy Sumeet Yadav @ ASH ISTH HTRSFellows Hemostasis and Thrombosis Research Society

Hot off the press in Annals of Oncology: Is adjuvant ribociclib ready for prime time? Recommended read in preparation for the NATALEE 4y update at #ESMO24 annalsofoncology.org/article/S0923-…

~1 week to #ESMO24, here is a📝 of 🔑abstracts for general onc that could change/reinforce our SoC! - #NIAGARA - #KN522 - #NATALEE - #DB12 - #MARIPOSA2 - #KRYSTAL12 - #NICHE2 - #SAKK41 - #POD1UM - #KN811 #BCSM #GISM #LCSM #MedTwitter #GUSM #OncTwitter ESMO - Eur. Oncology OncoAlert

Thought-provoking study out of the Flatiron Health real-world database. Omission of 5-FU Bolus assoc w/ decreased side-effect, and no change in outcomes. Many caveats: retrospective data, nuance of adjusting for "baseline clinical characteristics". jnccn.org/view/journals/…